FindTrial
Sign In

Safety assessment of oral intake of Glycine: Systematic review

Safety assessment of oral intake of Glycine: Systematic review - Safety assessment of oral intake of L-Arginine

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000046133
Enrollment
100
Registered
2025-04-01
Start date
2021-03-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sujects who has received L-arginine by oral in intervention study

Interventions

None listed

Sponsors

Yokohama University of Pharmacy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A double-blind comparative study of human studies in which L-Arg was orally ingested.

Exclusion criteria

Exclusion criteria: 1.Study without oral intake of L-Arg 2.Trial using substances other than L-Arg 3.Study that is not a human test such as animal experiments 4.A study that is not a double-blind comparative study

Design outcomes

Primary

MeasureTime frame
All of adverse events during intervention period—

Countries

Japan

Contacts

Public ContactKohsuke Hayamizu

Yokohama University of Pharmacy Laboratory of Food Chemistry

k.hayamizu@hamayaku.ac.jp045-859-1300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026